Results 331 to 340 of about 1,931,209 (398)
Astrocytic Ryk signaling coordinates scarring and wound healing after spinal cord injury. [PDF]
Shen Z+8 more
europepmc +1 more source
Advances in 3D and 4D Printing of Soft Robotics and Their Applications
This article summarizes the development of 3D‐printed soft robotics in the recent decade. The article discusses the printing capabilities of different additive manufacturing technologies in terms of soft polymers, multimaterial printability, soft robotic printing, and 4D printing.
Hao Liu+5 more
wiley +1 more source
Pathophysiologic Mechanisms of Severe Spinal Cord Injury and Neuroplasticity Following Decompressive Laminectomy and Expansive Duraplasty: A Systematic Review. [PDF]
Archavlis E+5 more
europepmc +1 more source
Using cloud computing technology, a telerehabilitation application allows patients to perform exercises remotely. Sensor data from a textile‐based IoT glove is processed in the cloud and transmitted as exercise commands to an actuating T‐IoT glove worn by patients.
Kadir Ozlem+5 more
wiley +1 more source
Ruptured arteriovenous malformation of Conus medullaris in infancy: A case report of an extremely rare emergency. [PDF]
Le TA, Pham HN, Bui MH, Anh NCT.
europepmc +1 more source
Early diagnosis and prognosis prediction of central nervous system infections are critical. This study introduces a deep‐learning model utilizing cerebrospinal fluid immune‐cell morphology captured via 3D holotomography. The model effectively predicts infection etiology and prognosis, achieving high accuracy.
Bo Kyu Choi+5 more
wiley +1 more source
Gallic acid protect against spinal cord ischemia-reperfusion injury in rat via activation of Nrf2/HO-1 signaling. [PDF]
Liu Z+5 more
europepmc +1 more source
Sex and age differences in glia and myelin in nonhuman primate and human spinal cords: implications for pathology. [PDF]
Poulen G+9 more
europepmc +1 more source
ABSTRACT Allogeneic hematopoietic stem‐cell transplantation (HCT) remains the only potentially curative therapy for patients with myelodysplastic neoplasms (MDS) and myelofibrosis (MF) and is the standard care for eligible patients with higher‐risk disease. Despite significant advancements, both diseases pose unique challenges due to their clinical and
Nico Gagelmann, Nicolaus Kröger
wiley +1 more source